Antithrombin is a major plasma protein inhibitor of proteinases generated during blood
coagulation; it plays an important role in the regulation of thrombin in blood. The …

T hefocusofthisreviewisonfindingsthathaveab… clinical issues and our understanding of the
biology of antithrombin. I appreciate the offer from the Editor-inchief to give the review a …

Abstract Antithrombin III (Human)(AT III) was administered to 18 patients with documented
hereditary AT III deficiency. In eight patients with no ongoing clinical symptoms of …

Patients with classical antithrombin deficiency (Type I) from seven unrelated kindreds were
studied by crossed immunoelectrophoresis of plasma in the presence and absence of …

The correct approach to the management of the asymptomatic carrier with a recognized
inherited thrombophilic disorder is uncertain because reliable in formation of the risk of …

W. ALWENS-FRANKFURT E. BILLIGHEIMER-FRANKFURT R. BING-BASEL K. BINGOLD-
HAMBURG O. BUMKE-MÜNCHEN. C. CHAGAS-RIO DE JANEIRO. M. CLOETTA-ZÜRICH …

A 31-year-old woman developed disturbance of consciousness and left hemiparesis.
Cerebral computed tomograms showed a low-density area in the right temporal lobe that …

HUMAN ANTITHROMBIN III is a single chain plasma glycoprotein of molecular mass of
approximately 60,000 daltons. I-3It is the primary inhibitor of the activated clotting factors lIa …

Hemostasis is the term applied to the process that regulates the loss of blood from the
circulatory system following injury. It involves three interrelated physiological mechanisms …

We previously reported a variant antithrombin III (AT III Kumamoto) associated with a 31-
year-old female who suffered from recurrent thrombotic episodes (1). To define the …